IT8467767A1 - Preparati farmaceutici ad attività antimicrobica e procedimento per la loro preparazione. - Google Patents

Preparati farmaceutici ad attività antimicrobica e procedimento per la loro preparazione.

Info

Publication number
IT8467767A1
IT8467767A1 IT1984A67767A IT6776784A IT8467767A1 IT 8467767 A1 IT8467767 A1 IT 8467767A1 IT 1984A67767 A IT1984A67767 A IT 1984A67767A IT 6776784 A IT6776784 A IT 6776784A IT 8467767 A1 IT8467767 A1 IT 8467767A1
Authority
IT
Italy
Prior art keywords
procedure
preparation
pharmaceutical preparations
antimicrobial activity
antimicrobial
Prior art date
Application number
IT1984A67767A
Other languages
English (en)
Other versions
IT8467767A0 (it
IT1179029B (it
Original Assignee
The Liposome Company Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Liposome Company Inc filed Critical The Liposome Company Inc
Publication of IT8467767A0 publication Critical patent/IT8467767A0/it
Publication of IT8467767A1 publication Critical patent/IT8467767A1/it
Application granted granted Critical
Publication of IT1179029B publication Critical patent/IT1179029B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT67767/84A 1983-08-01 1984-08-01 Preparati farmaceutici ad attivita antimicrobica e procedimento per la loro preparazione IT1179029B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51891283A 1983-08-01 1983-08-01
US06/633,481 US5000958A (en) 1983-08-01 1984-07-26 Enhancement of pharmaceutical activity

Publications (3)

Publication Number Publication Date
IT8467767A0 IT8467767A0 (it) 1984-08-01
IT8467767A1 true IT8467767A1 (it) 1986-02-01
IT1179029B IT1179029B (it) 1987-09-16

Family

ID=27059635

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67767/84A IT1179029B (it) 1983-08-01 1984-08-01 Preparati farmaceutici ad attivita antimicrobica e procedimento per la loro preparazione

Country Status (11)

Country Link
US (1) US5000958A (it)
EP (1) EP0153364B1 (it)
AU (1) AU3219484A (it)
CA (1) CA1237671A (it)
DE (1) DE3483322D1 (it)
ES (1) ES8603264A1 (it)
IL (1) IL72545A (it)
IT (1) IT1179029B (it)
PT (1) PT79012A (it)
SG (1) SG18592G (it)
WO (1) WO1985000515A1 (it)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU588299B2 (en) * 1985-04-08 1989-09-14 Rafa Laboratories Ltd. Artificial microcompartmentalization
US5409704A (en) * 1985-06-26 1995-04-25 The Liposome Company, Inc. Liposomes comprising aminoglycoside phosphates and methods of production and use
DE3689769T2 (de) * 1985-07-05 1994-07-21 Liposome Co Inc Multilamellare liposome mit verbesserter einschliessungswirkung.
FR2628317B1 (fr) * 1988-03-09 1991-11-08 Lvmh Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant
MX9203504A (es) * 1988-04-20 1992-07-01 Liposome Co Inc Complejo agente: lipido activo de alta proporcion.
ATE108651T1 (de) * 1988-05-20 1994-08-15 Liposome Co Inc Aktives mittel: lipid-komplex mit hohem verhältnis.
CA1340241C (en) * 1988-06-08 1998-12-15 Fountain Pharmaceuticals, Inc. Method for marking solvent dilution microcarriers
US5269979A (en) * 1988-06-08 1993-12-14 Fountain Pharmaceuticals, Inc. Method for making solvent dilution microcarriers
US4952405A (en) * 1988-10-20 1990-08-28 Liposome Technology, Inc. Method of treating M. avium infection
ATE147633T1 (de) * 1988-10-27 1997-02-15 Univ Minnesota Immunhilfsmittel aus liposome enthaltend lymphokin il -2
CA2057909C (en) * 1989-05-25 2000-01-11 Technology Unlimited, Inc. Cutaneous delivery of organic materials
ZA911974B (en) * 1990-03-21 1994-08-22 Res Dev Foundation Heterovesicular liposomes
US5264220A (en) * 1991-11-12 1993-11-23 Long David M Jr Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
EP0624095B2 (en) * 1991-12-31 2005-07-20 Zymogenetics, Inc. Methods and compositions for reducing blood loss
EP0585514B1 (en) * 1992-01-09 1998-10-07 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d., Ljubljana Animal feed and an additive thereto or to drinking water containing an antibiotic mixture of gentamicin with lincomycin or clindamycin
US5674855A (en) * 1992-08-12 1997-10-07 The Rogosin Institute Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
US5344822A (en) * 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy
WO1994012155A1 (en) * 1992-12-02 1994-06-09 Vestar, Inc. Antibiotic formulation and process
US5958449A (en) * 1992-12-02 1999-09-28 Nexstar Pharmaceuticals, Inc. Antibiotic formulation and use for bacterial infections
US5759571A (en) * 1993-05-11 1998-06-02 Nexstar Pharmaceuticals, Inc. Antibiotic formulation and use for drug resistant infections
US5478819A (en) * 1993-06-23 1995-12-26 Simo Tarpila Phospholipid composition and use thereof
DK0759774T3 (da) * 1993-09-22 2002-10-07 Xoma Technology Ltd Fremgangsmåde til behandling af gram-negativ bakteriel infektion ved indgivelse af baktericidt/permeabilitet-forøgende (BPI) proteinprodukt og antibiotikum
EP0664117A1 (de) * 1994-01-25 1995-07-26 F. Hoffmann-La Roche Ag Liposomenlösungen
BR9508584B8 (pt) * 1994-08-10 2014-11-18 Sepsicure L L C Composição farmacêutica isenta de peptídeo e proteína e adequada para administração intravenosa
US20020028215A1 (en) 1999-08-09 2002-03-07 Jagath L. Kadurugamuwa Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
US6096336A (en) * 1996-01-30 2000-08-01 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
US5874105A (en) * 1996-01-31 1999-02-23 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
US6183774B1 (en) 1996-01-31 2001-02-06 Collaborative Laboratories, Inc. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
US6071535A (en) * 1996-01-31 2000-06-06 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
IL126918A (en) 1996-05-08 2007-06-03 Biogen Idec Inc Ret ligand (retl) for stimulating neural and renal growth
WO1998006435A2 (en) * 1996-08-14 1998-02-19 Vanderbilt University COMPOSITIONS OF ANTICHLAMYDIAL AGENTS FOR THE DIAGNOSIS AND MANAGEMENT OF INFECTION CAUSED BY $i(CHLAMYDIA)
US5935572A (en) * 1997-01-10 1999-08-10 Collaborative Laboratories, Inc. Composition containing protease separate from glycosidase for removing nits in treating lice infestation
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
US6352996B1 (en) 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
AU2002334761A1 (en) * 2001-10-01 2003-04-14 The Board Of Trustees Of The University Of Illinois Methods of treating drug-resistant bacterial infections
US7850990B2 (en) 2001-10-03 2010-12-14 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
US20080075762A1 (en) * 2001-10-03 2008-03-27 Paul Tardi Compositions for delivery of drug combinations
CA2383259A1 (en) 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
WO2003070181A2 (en) * 2002-02-19 2003-08-28 Eden Research Plc Compositions and methods for preservation of food
AU2003230600B2 (en) * 2002-03-05 2009-06-04 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
AU2003304204B2 (en) * 2002-10-29 2009-12-24 Insmed Incorporated Sustained release of antiinfectives
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US6846966B2 (en) * 2002-11-26 2005-01-25 Exxonmobil Chemical Patents Inc. Method and apparatus for treating oxygenate-containing feeds and their use in conversion of oxygenates to olefins
FR2852513A1 (fr) * 2003-03-17 2004-09-24 Groupe Lepine Combinaison d'antibiotiques gentamicine/clindamycine et ses applications aux ciments orthopediques curatifs
CN100351265C (zh) 2003-04-02 2007-11-28 美国政府健康及人类服务部 含胆固醇的化合物以及其用作针对伯氏疏螺旋体(Borrelia burgdorferi)的免疫原的应用
US20040204435A1 (en) * 2003-04-09 2004-10-14 Joachim Liehr Alternating treatment with topoisomerase I and topoisomerase II inhibitors
AU2005229434B2 (en) 2004-03-30 2010-09-30 Nsgene A/S Therapeutic use of a growth factor, NsG33
WO2006013462A2 (en) * 2004-07-30 2006-02-09 Nsgene A/S Growth factors nsg28, nsg30, and nsg32
CA2581133A1 (en) * 2004-09-20 2006-03-30 British Columbia Cancer Agency Free or liposomal gemcitabine alone or in combination with free or liposomal idarubicin
US20110020434A1 (en) * 2005-09-02 2011-01-27 O'halloran Thomas V Nanoparticle arsenic-platinum compositions
DE102005063375A1 (de) * 2005-09-15 2007-04-19 Schülke & Mayr GmbH Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen
US8067433B2 (en) 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
ES2798263T3 (es) 2005-12-08 2020-12-10 Insmed Inc Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
WO2008137717A1 (en) 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US8470762B2 (en) 2007-05-31 2013-06-25 Colgate-Palmolive Company Fabric softening compositions comprising polymeric materials
US20110218140A1 (en) * 2008-02-25 2011-09-08 Gonsalves Kenneth E Biodegradable therapeutic nanoparticles containing an antimicrobial agent
EP3246034A1 (en) 2008-03-06 2017-11-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
WO2011006073A1 (en) 2009-07-10 2011-01-13 President And Fellows Of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
JP6200648B2 (ja) 2009-12-18 2017-09-20 アケリオス セラピューティクス，インコーポレーテッド 三叉神経・自律神経性頭痛、片頭痛、および血管症状の治療および予防のための組成物
US8716478B2 (en) 2010-01-27 2014-05-06 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
EP2580242B1 (en) 2010-06-14 2016-04-06 H. Lundbeck A/S Modulation of the interaction between sorla and gdnf-family ligand receptors
ES2606781T3 (es) * 2010-07-23 2017-03-27 Acea Biotech, Inc. Macrólidos polienos antifúngicos y antiparasitarios
JP6149226B2 (ja) 2010-10-01 2017-06-21 ホーバ セラピューティクス アンパルトセルスカブ アロディニア、痛覚過敏、自発痛及び幻肢痛の処置
PL2852391T3 (pl) 2012-05-21 2022-04-11 Insmed Incorporated Układy do leczenia infekcji płuc
CA2891487A1 (en) 2012-11-29 2014-06-05 Insmed Incorporated Stabilized vancomycin formulations
MX384843B (es) 2014-05-15 2025-03-14 Insmed Inc Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas.
US10791740B2 (en) 2014-06-06 2020-10-06 The Curators Of The University Of Missouri Enhancement of antibiotic efficacy
CN107614061A (zh) 2014-12-01 2018-01-19 阿科莱尔斯疗法公司 用于治疗与疼痛有关的偏头痛和病症方法和组合物
US11021443B2 (en) 2015-08-03 2021-06-01 President And Fellows Of Harvard College Charged ion channel blockers and methods for use
WO2018035380A1 (en) 2016-08-17 2018-02-22 Solstice Biologics, Ltd. Polynucleotide constructs
US11597744B2 (en) 2017-06-30 2023-03-07 Sirius Therapeutics, Inc. Chiral phosphoramidite auxiliaries and methods of their use
EP3773505B1 (en) 2018-03-30 2026-04-29 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
EP3787602A4 (en) 2018-05-02 2022-03-23 Insmed Incorporated PROCESS FOR THE MANUFACTURE OF LIPOSOMAL DRUG FORMULATIONS
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11377422B2 (en) 2019-03-11 2022-07-05 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CA3129089A1 (en) 2019-03-11 2020-09-17 Bridget Mccarthy Cole Ester substituted ion channel blockers and methods for use
CN113811305A (zh) 2019-03-11 2021-12-17 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法
WO2020227646A1 (en) 2019-05-09 2020-11-12 Apkarian Technologies Llc Methods and compositions for treating pain
EP4021934A4 (en) 2019-08-30 2024-02-14 The Regents of the University of California METHODOLOGIES FOR SCREENING FOR OVEREXPRESSION OF GENE FRAGMENTS AND RELATED USES
CA3155568A1 (en) 2019-11-06 2021-05-14 Bridget Mccarthy Cole Charged ion channel blockers and methods for use
AU2020380118B2 (en) 2019-11-06 2026-06-11 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US20230338495A1 (en) * 2020-08-19 2023-10-26 Vitruviae LLC Vaccine Compositions and Antibodies For Lyme Disease
JP2024518433A (ja) 2021-05-06 2024-05-01 ホバ セラピューティクス エーピーエス 化学療法誘発性神経障害性疼痛の予防及び治療
KR20240118796A (ko) 2021-12-10 2024-08-05 호바 세라퓨틱스 에이피에스 침해수용성 통증의 치료

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231981A (en) * 1975-08-18 1977-03-10 Takeda Chem Ind Ltd Microcapsule preparation method
US4356167A (en) * 1978-01-27 1982-10-26 Sandoz, Inc. Liposome drug delivery systems
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4328222A (en) * 1978-11-21 1982-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions for parenteral or local administration
US4241046A (en) * 1978-11-30 1980-12-23 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase

Also Published As

Publication number Publication date
EP0153364A4 (en) 1987-03-03
WO1985000515A1 (en) 1985-02-14
IT8467767A0 (it) 1984-08-01
ES542147A0 (es) 1985-12-16
EP0153364A1 (en) 1985-09-04
PT79012A (en) 1984-09-01
CA1237671A (en) 1988-06-07
US5000958A (en) 1991-03-19
DE3483322D1 (de) 1990-10-31
IT1179029B (it) 1987-09-16
AU3219484A (en) 1985-03-04
IL72545A (en) 1987-11-30
SG18592G (en) 1992-04-16
EP0153364B1 (en) 1990-09-26
ES8603264A1 (es) 1985-12-16

Similar Documents

Publication Publication Date Title
IT8467767A0 (it) Preparati farmaceutici ad attivita antimicrobica e procedimento per laloro preparazione
IT1158039B (it) 2-/4-/(4,4-dialchil-2,6-piperidindion-1-il)-butil/1-piperazinil/pirimidine ad attivita' ansiolitica selettiva, procedimento per la loro preparazione e preparati farmaceutici che le contengono
FI844775A7 (fi) Sfingosiinijohdannaisia, niiden valmistusja farmaseuttinen valmiste.
FI881061A7 (fi) Hitaasti vapauttavia valmisteita ruoansulatuskanavan ulkopuolisesti annettaviksi ja niiden käyttö.
IT8324035A0 (it) Cefem composti ad attivita'farmaceutica e procedimenti per laloro preparazione.
BR8802557A (pt) Agente fisiologicamente ativo para uso agricola
IT8421241A0 (it) Composti ad attivita'antibatterica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
ZA845682B (en) Benzamidine derivatives having an antimicrobial activity process for their preparation and use as disinfectant drugs or preservatives
FI853228A7 (fi) Uudet -butyrolaktaamit, niiden farmaseuttisesti aktiiviset koostumukset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkeaineina.
IT1229223B (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
IT1224701B (it) Preparati farmaceutici antimicrobici per applicazione topica e procedimento per la loro produzione
IT8320468A0 (it) Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.
IT1167746B (it) Nitroimidazoli ad attivita' tricomonacida, procedimento per la loro preparazione e relative composizioni farmaceutiche
FI853368A7 (fi) Uusia pseudo-oligosakkarideja, joilla on -glukosidaasia estävä vaikutus, menetelmä niiden valmistamiseksi, niiden käyttö ja farmaseuttisia valmisteita.
IT1212753B (it) Composti polienici,procedimento per la loro preparazione e preparati farmaceutici che li contengono
IT1211944B (it) Derivati azolici,procedimento per la loro produzione,preparati farmaceutici che li contengono,e loro impiego
IT8321607A1 (it) Preparati farmaceutici topici ad attività antisettica ed antiinfiammatoria spinta, e procedimento per la loro preparazione
IT8567216A0 (it) Composti pteridinici relativi procedimenti di preparazione e preparati farmaceutici che li contengono
IT1196147B (it) Preparati farmaceutici con azione antitumorale
FI821332A7 (fi) Sydänlääkkeinä käyttökelpoisia pyratsolipyridiinijohdannaisia sekä niiden valmistus.
IT8520653A0 (it) Composti ad attivita'antibatterica, loro preparazione e composizioni farmaceutiche relative.
IT1168615B (it) Composti di amminoimidazolile, procedimenti per la loro produzione e preparati farmaceutici che contengono questi composti
IT8519065A0 (it) Composti con attivita' antitossica ed antianemica, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8222494A0 (it) Derivati ad attivita'espettorante, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
IT8321358A0 (it) Derivati ad attivita' terapeutica della s-carbossimetilcisteina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.